As of Jul 31
| +2.57 / +2.15%|
The 5 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 135.00, with a high estimate of 149.00 and a low estimate of 122.00. The median estimate represents a +10.33% increase from the last price of 122.36.
The current consensus among 5 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.